Copertina

JAK Inhibitors for Granuloma Annulare: Hope for Refractory Cases?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Defne Özkoca, Seçil Vural
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	International Journal of Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Practices, Motivations, Barriers, and Social Media Influence in Cosmetic Botulinum Toxin Use: A Cross‐Sectional National Survey
di: Laşin Özbek, et al.
Pubblicazione: (2025)

JAK inhibitors: Unveiling varicella and herpes risks in atopic dermatitis
di: Defne Baskurt, et al.
Pubblicazione: (2024)

Association Between Familial Inflammatory Diseases and Hidradenitis Suppurativa Severity: A Single‐Center Study
di: Defne Özkoca, et al.
Pubblicazione: (2025)

Refractory Disseminated Annular Elastolytic Giant Cell Granuloma Successfully Treated With Upadacitinib: A Case Report
di: Gabriele Poddine, et al.
Pubblicazione: (2025)

Evaluating dietary considerations in hidradenitis suppurativa: a critical examination of existing knowledge
di: Seçil Vural, et al.
Pubblicazione: (2024)

Subcutaneous Granuloma Annulare: Diagnosis and Imaging
di: Emir Q. Haxhija
Pubblicazione: (2026)

Oral Roflumilast for the Treatment of Generalized Granuloma Annulare: A Small Case Series
di: Núria Riera‐Martí, et al.
Pubblicazione: (2025)

Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety
di: Sama Heidari, et al.
Pubblicazione: (2025)

Novel Use of a Topical JAK / STAT Inhibitor in the Management of Refractory Erythromelalgia: A Case Report
di: Alexandra Gershman, et al.
Pubblicazione: (2026)

Association of Treatment Burden With Quality of Life and Distress in Hidradenitis Suppurativa
di: Defne Özkoca, et al.
Pubblicazione: (2026)

Erythema Annulare Centrifugum Following PD ‐1 Inhibitor Therapy in Melanoma: A Case Report
di: Leticia Szadai, et al.
Pubblicazione: (2026)

JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
di: Megan M. Mukenge, et al.
Pubblicazione: (2025)

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
di: Mariano Ara‐Martín, et al.
Pubblicazione: (2025)

Vaccination Strategies in Atopic Dermatitis Patients Treated With JAK Inhibitors
di: Nóra Belső
Pubblicazione: (2025)

Call to Action: JAK Inhibitor Access and Advocacy for Alopecia Areata Patients
di: Carli D. Needle, et al.
Pubblicazione: (2025)

Eosinophilic Annular Erythema: Report of a Case and Successful Management
di: Veronica Castellanos‐Molina, et al.
Pubblicazione: (2025)

Efficacy of Tralokinumab in Atopic Dermatitis Patients With Prior Biologic and JAK Inhibitor Therapy
di: Alexandra Nigro, et al.
Pubblicazione: (2026)

Successful Treatment of Refractory Generalized Granuloma Annulare with Upadacitinib
di: Alexis Coican, et al.
Pubblicazione: (2024)

Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis–Eczema Overlap ( PsEma ): A Retrospective Study
di: Marley Cutrona, et al.
Pubblicazione: (2026)

Successful Treatment of Mesotherapy Induced Granuloma Annulare With Baricitinib
di: Li Wang, et al.
Pubblicazione: (2025)

A Prospective Study Evaluating the Prevalence of Arthralgia and Other Inflammatory Comorbidities Among Hidradenitis Suppurativa Patients
di: Tuğba Tehçi, et al.
Pubblicazione: (2026)

Upadacitinib Attenuates Hypervascularization in Facial Foreign Body Granuloma—A Case Report With Imaging Evidence
di: Yangyiyi Yu, et al.
Pubblicazione: (2025)

Risk of Cardiovascular Disease and Cancer in Patients Initiating JAK Versus IL‐4/‐13 Inhibitors for Atopic Dermatitis
di: Sizheng Steven Zhao, et al.
Pubblicazione: (2025)

A 52‐Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors
di: Claudio Brescia, et al.
Pubblicazione: (2026)

Acne Lesions Induced by Oral JAK Inhibitors Include Comedones: Insights From Six Patients Without Any Prior History of Acne
di: Sarina Ban, et al.
Pubblicazione: (2026)

Successful Treatment of Refractory Severe Pemphigus With Telitacicept as Adjunctive Therapy: Two Case Reports
di: Jiefeng Jiang, et al.
Pubblicazione: (2025)

Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report
di: Shota Nakayama, et al.
Pubblicazione: (2025)

Tattoo‐Associated Systemic Sarcoidosis Treated With JAK Inhibition
di: Laura Membrillo Ruiz, et al.
Pubblicazione: (2026)

Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies
di: Luca Bettolini, et al.
Pubblicazione: (2025)

JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
di: Juan Ruano
Pubblicazione: (2025)

Infection risk with JAK inhibitors in dermatoses: a meta‐analysis
di: Patrick A. Ireland, et al.
Pubblicazione: (2024)

Topical Cyclosporine 5% in Pentravan for Refractory Discoid Lupus Erythematosus: Clinical Remission in a 15 Patients Case Series
di: Caterina Maria Rosaria Giorgio, et al.
Pubblicazione: (2025)

Oral JAK Inhibitors as a Promising Therapeutic Strategy for Refractory Rosacea: A Systematic Review and Meta‐Analysis
di: Yu Peng, et al.
Pubblicazione: (2026)

Treatment of Refractory Extensive Ulcerative Necrobiosis Lipoidica With Infliximab
di: Ishana Dixit, et al.
Pubblicazione: (2025)

Refractory Normocomplementemic Urticarial Vasculitis With Sustained Remission on Upadacitinib
di: Emily A. Bogdanski, et al.
Pubblicazione: (2026)

Clinical and Photobiological Response to Omalizumab in Refractory Solar Urticaria
di: Alessia Pacifico, et al.
Pubblicazione: (2026)

Delayed Foreign Body Granulomas Following Dermal Fillers in a Breast Cancer Patient After Chemotherapy: A Diagnostic Challenge
di: Elif Afacan Yıldırım, et al.
Pubblicazione: (2025)

Erosive Mucocutaneous Eruptions in Patients Treated With Immune Checkpoint Inhibitors: A Case Series
di: Valerie Jaroenpuntaruk, et al.
Pubblicazione: (2026)

Refractory Pediatric Generalized Pustular Psoriasis Successfully Treated With Spesolimab
di: Bo Peng, et al.
Pubblicazione: (2025)

Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports
di: Christoph Zeyen, et al.
Pubblicazione: (2026)